How many clinical trials are there for Healthy?

PlainTrial tracks 1096 US clinical trials for Healthy, of which 225 are currently recruiting.

Which interventions appear most often on Healthy trial records?

Placebo is the most-linked intervention name on Healthy records (100 trial links), followed by Placebo. Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Healthy?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 225 recruiting now early-phase tilt #2 of 28,707 conditions

Healthy: early-phase trial registry

Compiled by PlainTrial · August 8, 2026

225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1,096 US clinical trials · 225 currently recruiting · #2 of 28,707 conditions by registered trial count

Healthy: 1,096 US clinical trials tracked, 225 recruiting.

Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.

Enrollment posture brief

Registry condition healthy

Volume-matched condition peers

Nearest open-share peer: Psoriasis (20% recruiting · 127 trials)

Open-enrollment share among volume-matched conditions near Healthy

Healthy lists 225 open slots (21% of 1,096 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Healthy is recruiting below its size-band peers.

225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Sponsorship of Healthy trials is spread across many organizations.

Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.
Most Healthy trials plan to enrol fewer than 100 people.

Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.
Healthy research is mostly interventional.

905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Open and recent trials

1,096 total, page 16 of 22

COMPLETED Phase 1 31 participants

Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C

MassBiologics

NCT00952263

COMPLETED NA 31 participants

Neuromodulation of Cognition in Older Adults

University of Florida

NCT02137122

COMPLETED Phase 1 31 participants

Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males

Celgene

NCT01712828

COMPLETED NA 31 participants

Food Containing Resistant Starch Type 4 and Postprandial Glycemic Response

Clinical Nutrition Research Center, Illinois Institute of Technology

NCT03844503

Key findings

Open and recent trials

Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C

Neuromodulation of Cognition in Older Adults

Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males

Food Containing Resistant Starch Type 4 and Postprandial Glycemic Response

A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)

Neuroimaging of Anesthetic Modulation of Human Consciousness

Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of Ricin

A Phase 1 Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics of Tivozanib in Healthy Subjects

Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers

Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers

Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants

Use of Transcranial Magnetic Stimulation (TMS) and Magnetic Resonance Imaging (MRI) to Study Visual Attention

Energy Expenditure

Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers

Staccato® Granisetron Multiple Dose PK

Electromyography to Diagnose Neuromuscular Disorders

Metronidazole Drug Interaction Study With MMX® Mesalazine/Mesalamine

Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants

A Comparison Study of Three Standard Elbow Wrist Hand Orthoses to Limit Forearm Rotation

A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions

Cilostazol 50 mg Tablets Under Fasting Conditions

Chiropractic Force Versus Touch

A Study to Evaluate Endoflip Normal Ranges Data in Healthy Volunteers

Emotion Regulation and Cancer Caregiving

A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions

A Study of LY3090106 in Japanese and Caucasian Healthy Participants

Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide)

A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions

Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers

Comparing the Effects of Upper and Lower Body Resistance Training on Pain Sensitivity

Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine

A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants

A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems

Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00025

Evaluating the Availability of Berry Phytonutrients Post-consumption of Fresh and Processed Blueberry by Healthy Adults

A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function

Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles

Bioavailability Study Comparing Tolvaptan Administered Via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact

An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers

A Study of the Effect of Itraconazole and Phenytoin on Calderasib (MK-1084) in Healthy Adults (MK-1084-008)

Circulatory Levels of Irisin in Response to Acute Resistance Training

Assessing Student Learning of Spinal Mobilization With Real-time Objective Feedback

Does Mindfulness Training Change the Processing of Social Threat?

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants

A Study to Assess ACH-0145228 When Administered as Immediate Release Tablet Versus Powder-In-Capsule in Healthy Adult Participants

To Assess the Bioequivalence of Two Pacritinib Drug Product Formulations and FMI Formulation Following Oral Administration in Healthy Subjects

Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects

A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Participants

Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin

Phase Distribution

Top Sponsors

Named interventions

US sites by state

Related